Alcon Inc. reports developments in eye care through its Surgical and Vision Care businesses. Company news commonly covers quarterly results, constant-currency sales trends, product-launch momentum and portfolio updates across cataract and vitreoretinal surgical systems, intraocular lenses, contact lenses, lens-care products and ocular health.
Recurring updates also include launches and milestones for products such as Clareon, PanOptix, Vivity, TOTAL30, Precision7, Tryptyr and Unity, along with annual general meeting items, board elections, compensation votes, dividends, share repurchase authorizations, acquisitions, integration costs, R&D spending and other governance or capital-allocation actions.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Alcon (SIX/NYSE: ALC) will host its first in-person Annual General Meeting (AGM) since becoming independent in April 2019, on May 5, 2023. Key agenda items include approving annual financial statements for 2022 and the Board's proposal for a CHF 0.21 cash dividend per share, expected to be payable around May 12, 2023. The Board also proposes amendments to the Articles of Incorporation to align with recent Swiss corporate law reforms. Notably, no future virtual AGMs will be approved. Shareholders will vote on compensation for Board and Executive Committee members, among other items.
Alcon has received the Silver Anthem Award for its innovative compliance training program, The Lens, recognized as the Best Special Workforce Initiative: Health in the 2nd Annual Anthem Awards. Developed by Alcon’s Legal and Compliance team in collaboration with Labyrinth Training, The Lens features five interactive episodes addressing various compliance topics. Launched globally in 17 languages, it achieved an impressive completion rate of 81% among associates within 60 days. This recognition follows several other accolades received by Alcon, including awards for leadership and corporate social responsibility.